Developments in age-related macular degeneration: Diagnosis and treatment

Geriatrics

Volumn 64, Issue 3, 2009, Pages 16-19

  Kaufman, Stephen R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Exudative; Macula; Non exudative; Retina

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; VERTEPORFIN; MONOCLONAL ANTIBODY; VASCULOTROPIN;

AGED; BLINDNESS; CATARACT; DRUG COST; DRUG EFFICACY; EYE EXAMINATION; GLAUCOMA; HUMAN; LASER COAGULATION; PHOTODYNAMIC THERAPY; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; THROMBOEMBOLISM; VISUAL IMPAIRMENT; DRUG ANTAGONISM; RETINA MACULA DEGENERATION; REVIEW;

AGED; ANTIBODIES, MONOCLONAL; HUMANS; LIGHT COAGULATION; MACULAR DEGENERATION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 64249173249     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. The American Academy of Ophthalmology Sets its Sight on Healthy Vision Month. Press release, 05/01/2006. http://www.aao.org/newsroom/release/20060501. cfm?RenderForPrint=1&|~http://www.aao.org/newsroom/release/20060501.cfm? RenderForPrint=1& [http://www.aao.org/newsroom/release/20060501.cfm? renderforprint=1&|~http://www.aao.org/newsroom/release/20060501.cfm? renderforprint=1&%0a] Accessed February 6, 2009.
2. Corn AL, Koenig AJ, eds. Foundations of Low Vision: Clinical and Functional Perspectives. New York: AFB Press, 1996;446.
3. Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol. 2001;119(2):198-207.
4. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 2005;112(2):301-304. (Pubitemid 40202568)
5. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351(27):2805-2816.
6. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36(4):331-335.
7. Rich RM, Rosenfeld, PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2006;26(5):495-511.
8. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431.
9. American Society of Retinal Specialists. Report for PAT Mini-Survey Wet AMD Treatment. ASRS, 2006. www.asrs.org.
10. Bevacizumab. Physician's Desk Reference. Montvale, NJ: Thompson Healthcare, Inc., 2008;1199.
11. Clinical trials update. Retinal Physician. 2009 (January):57-62.
12. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol. 2006;124(7):995-1001.
13. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126(6):826-833.
14. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
15. Moeller SM, Parekh N, Tinker L, et al; CAREDS Research Study Group. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006;124(8):1151-1162.
16. Coleman H, Chew E. Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol. 2007;18(3):220-223.
17. Allikmets R. AMD genetic studies focus on alternative complement pathway. Retina Today. 2008;3(4):39-40.
18. Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2007;114(6):1143-1150. (Pubitemid 46829381)
19. Trevino R, Kynn MG. Macular function surveillance revisited. Optometry. 2008;79(7):397-403.